Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA, Everyday Health join forces

This article was originally published in The Tan Sheet

Executive Summary

The agency's collaboration with consumer health information network Everyday Health will allow FDA's food and medical product safety alerts and postings about wellness and prevention to reach Everyday Health's 30 million unique monthly visitors. The Web site's owner, Waterfront Media, and FDA launched the co-branded portal, and will jointly publish a weekly newsletter on drug safety, children's health products and cosmetics, according to a Nov. 17 release. FDA also works with WebMD to communicate with consumers (2"The Tan Sheet" Nov. 2, 2009, In Brief)

You may also be interested in...

FDA partners with will provide visitors FDA consumer updates through a partnership announced May 26. The arrangement will enhance FDA's "effort to ensure the public has easy access to reliable, useful information that can help people protect and improve their health," the agency says. FDA also partners with WebMD and Everyday Health to bolster consumer outreach (1"The Tan Sheet" Nov. 30, 2009, In Brief)

FDA, WebMD expand partnership

FDA and WebMD Health Corp. expand their partnership to provide consumers with increased access to FDA's consumer information, the agency says Oct. 29. The second phase of the partnership launched in December 2008 includes additional multimedia tools and content on WebMD's Web site about allergies and asthma, children's health, diabetes, heart health and vitamins and supplements, FDA says. A release says the partnership increased FDA's consumer reach when the agency warned the public to stop using Iovate Pharmaceuticals' weight-loss product Hydroxycut because of serious adverse event reports (1"Health News Daily" May 4, 2009)

European Parliament To Vote On MDR Delay As Council Rectifies Critical Mistake

The EU is pulling out all the stops to have the one-year delay to the MDR adopted before it is too late, and a crucial vote will take place on 16 April.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts